Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
400 studies found for:    "Diabetic Retinopathy"
Show Display Options
Rank Status Study
21 Completed The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Procedure: Ophthalmic Telemedicine
22 Completed Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil
Condition: Diabetic Retinopathy
Intervention:
23 Completed Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)
Condition: Diabetic Retinopathy
Intervention:
24 Completed Blood Factors and Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
25 Completed Propranolol for Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Propranolol
26 Completed Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Condition: Diabetic Retinopathy
Interventions: Procedure: Photography of the retina;   Procedure: Retinal photography
27 Completed Phenotyping Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
28 Completed Evaluation of Doxycyline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: doxycycline monohydrate;   Drug: placebo
29 Completed Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases
Condition: Diabetic Retinopathy
Interventions: Other: Tele-medicine;   Other: Conventional referral
30 Completed Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Retinal laser photocoagulation
31 Unknown  Computer-based Screening for Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
32 Completed Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Triamcinolone Acetonide 4 mg intravitreal injection;   Procedure: Panretinal photocoagulation
33 Unknown  Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Lucentis (ranibizumab)
34 Completed RETeval Study for Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Device: RETeval
35 Unknown  Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal photocoagulation;   Procedure: Procedure: Panretinal Photocoagulation (PRP) Drug: Intravitreous injection of Bevacizumab
36 Recruiting Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
Condition: Diabetic Retinopathy
Intervention: Other: Initiation of treatment of diabetes
37 Recruiting Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
Condition: Diabetic Retinopathy
Interventions: Drug: Aflibercept;   Drug: Sham
38 Terminated Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Trientine Hydrochloride;   Drug: Oral placebo capsules
39 Unknown  Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Pan retinal photocoagulation laser treatment
40 Completed Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: triamcinolone acetonide (Kenalog)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.